About
Us

YOUR TRUSTED PARTNER IN GENERIC PHARMACEUTICALS

Solaris Pharma is committed to enhancing healthcare access through the development and supply of essential, in demand medicines. We operate with a strong emphasis on quality, regulatory compliance, and operational excellence, ensuring that our generic portfolio is delivering global standards for safety, efficacy, and reliability.

Our business model emphasizes strategic sourcing, lifecycle management, and continuous improvement across manufacturing and distribution. By combining technical expertise with disciplined execution, Solaris Pharma delivers value across the pharmaceutical supply chain.

Our Mission

Solaris Pharma Corporation is committed to developing and delivering a broad portfolio of complex generic and specialty pharmaceutical products that provide patients with high-quality, affordable, and effective therapeutic alternatives—supported by scientific excellence, regulatory rigor, and manufacturing reliability.

Solaris Pharma Corporation is currently developing several topical, sterile and tablet products, which are in different stages of development. The company has a dedicated team of committed and well-trained scientists along with experienced program managers and regulatory personnel who provide a robust product development process. The entire end-to-end product development process has been validated through multiple product approvals. A scalable commercial infrastructure is in place to market our approved products. The commercial team has reinforced our success of timely product approvals by successfully launching multiple products under the Solaris label into the market. Solaris has established an excellent reputation of being a dependable supplier, trusted for consistent quality and reliable performance.

THE DOSAGE FORMS THAT ARE BEING DEVELOPED AT OUR FACILITY INCLUDE:

Topicals

Solutions

suspensions

Ophthalmics

Tablets

About Our COmpany

Our History

April 13, 2026

Brivaracetam Tablets 100mg

April 13, 2026

Brivaracetam Tablets 75mg

April 13, 2026

Brivaracetam Tablets 50mg

April 13, 2026

Brivaracetam Tablets 25mg

April 13, 2026

Brivaracetam Tablets 10mg

April 6, 2026

Clarithromycin Extended-Release Tablets 500mg

April 6, 2026

Clarithromycin Tablets 500mg

April 6, 2026

Clarithromycin Tablets 250mg

January 26, 2026

Nitroglycerin Ointment 0.4%

December 29, 2025

Moxifloxacin Tablets 400mg

June 10, 2025

Dicyclomine HCl Capsules 20mg

June 10, 2025

Dicyclomine HCl Capsules 10mg

March 18, 2024

Estradiol Gel 0.06%

November 3, 2023

Neomycin Sulfate Tablets 500mg

February 16, 2024

Tazarotene Gel 0.10%

February 1, 2024

Tazarotene Gel 0.05%

April 1, 2022

Clindamycin Phosphate & Tretinoin Gel 1.2%/0.025%

September 17, 2021

Metronidazole Vaginal Gel 0.75%

July 7, 2021

Clindamycin Phosphate Gel 1%, 75ml

EXPERIENCED LEADERSHIP

Solaris Pharma is led by an experienced management team with deep expertise in generic pharmaceuticals, regulatory affairs, quality assurance, supply chain management, and commercial operations.